Abstract

Heart problem is a problem in the electrical signals in the heart. Electrical signals initiate a regular heartbeat that comes from the heart pacemaker, the sinoatrial node (SA), which is located at the top of the right atrium. Although the AV block is relative, the third-degree AV block is respectively rare. The incidence in the general population appears to be low, approximately 0.02% to 0.04 %. A 65-year-old male patient admitted in the hospital with chief complaints of giddiness with sweating and history of symptomatic AV-block with no chest pain, shortness of breath. Patient underwent surgery of Inserted temporary pacemaker, permanent pacemaker and D-Data direction register (DDDr). In clinical use, the adverse effects of QT-prolonging drugs can be checked by not exceeding the prescribed dose, withdrawing their use in patients with pre-existing cardiac disease, premature ventricular arrhythmias, and electrolyte imbalance such as hypokalemia. Simultaneous administration of drugs that inhibit the cytochrome P450. In emergency conditions, patients must keep in proper physicians and monitoring. This paper might help physician’s research scholars, nursing staff, and other healthcare departments.

Highlights

  • Heart problem is a problem in the electrical signals in the heart

  • Electrical signals initiate a regular heartbeat that comes from the heart pacemaker, the sinoatrial node (SA), which is located at the top of the right atrium [1]

  • The electrical signals transform to the lower chambers of the heart AV node

Read more

Summary

INTRODUCTION

Heart problem is a problem in the electrical signals in the heart. Electrical signals initiate a regular heartbeat that comes from the heart pacemaker, the sinoatrial node (SA), which is located at the top of the right atrium [1]. The electrical signals transform to the lower chambers of the heart AV node (atrioventricular node) Beta-adrenergicblockers and non-dihydropyridine calcium channel blockers (CCB) are considered a common cause of acquired complete AV block (atrioventricular) in clinical cardiology practice [5, 6]. It is unclear if AV block is identified in patients treated with betaadrenergic-blockers and calcium channel blockers. As a consequence of the high risk of AVblock recurrence despite the discontinuation of the suspected drug, about half of patients who have received Beta-blockers and CCB continuously develop AV-block require implantation of pacemaker [10].

DISCUSSION
CONCLUSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.